- Open Access
Correction: Shikonin inhibits cancer cell cycling by targeting Cdc25s
BMC Cancer volume 23, Article number: 461 (2023)
Correction: BMC Cancer 19, 20 (2019)
Following publication of the original article , the authors found an error when checking the raw data. The anti-CDC25B activity of two compounds with Western Blot experiments in the same batch were tested, and there was an overlap between the two batches when processing the data. To make sure of the certainty of the conclusions, we conducted another experiment and found that the results were consistent with those in the article. The corrected Western Blot results for Figs. 5 and 6C are given in this correction article.
Zhang S, Gao Q, Li W, et al. Shikonin inhibits cancer cell cycling by targeting Cdc25s. BMC Cancer. 2019;19:20. https://doi.org/10.1186/s12885-018-5220-x.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Zhang, S., Gao, Q., Li, W. et al. Correction: Shikonin inhibits cancer cell cycling by targeting Cdc25s. BMC Cancer 23, 461 (2023). https://doi.org/10.1186/s12885-023-10976-2